A study [396] showed that the treatment of A549 NSCLC cells with troglitazone (an activator of PPARγ) induced the conversion of LC3-I to LC3-II and increased the degradation of p62, indicating activation of autophagy flux while inducing apoptosis in A549 cells. The gene discussed is PPARG; the disease is non-small cell lung carcinoma.